This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| 21 U.S.C. § 1441 | |
|---|---|
| Title | 21 U.S.C. § 1441 |
| Enacted by | United States Congress |
| Enacted title | Title 21—Food and Drugs |
| Enacted year | 1938 |
| Amended by | Food, Drug, and Cosmetic Act, Drug Enforcement Administration Reorganization Act |
| Status | current |
21 U.S.C. § 1441 21 U.S.C. § 1441 is a statutory provision within Title 21 of the United States Code that addresses offenses and penalties related to controlled substances and food and drug misbranding under the Food, Drug, and Cosmetic Act, Controlled Substances Act, Federal Food, Drug, and Cosmetic Act amendments of 1962, and subsequent amendments. The section operates alongside enforcement programs administered by the Food and Drug Administration, Drug Enforcement Administration, Department of Justice (United States), and congressional committees such as the United States Senate Committee on the Judiciary and the United States House Committee on Energy and Commerce. It has been cited in statutory codifications, administrative rulemaking, and judicial opinions from the Supreme Court of the United States and various United States Courts of Appeals.
The statutory text of 21 U.S.C. § 1441 consists of numbered subsections and cross-references to other provisions in Title 21 of the United States Code, 21 U.S.C. § 331, 21 U.S.C. § 333, and provisions implementing penalties under the Controlled Substances Act of 1970. The structural arrangement follows the drafting conventions used in codifications by the Office of the Law Revision Counsel, the Library of Congress, and the Government Publishing Office. The provision forms part of a larger statutory chapter that includes definitions, inspection authorities, seizure powers, and judicial review mechanisms reflected in related statutes like 21 U.S.C. § 337 and 21 U.S.C. § 351.
Congressional enactments that shaped 21 U.S.C. § 1441 trace to the original Food, Drug, and Cosmetic Act enacted in 1938 during the administration of Franklin D. Roosevelt, later amended by landmark measures during the presidencies of John F. Kennedy, Lyndon B. Johnson, and Richard Nixon, including the Kefauver Harris Amendment and the Controlled Substances Act. Key committee reports and floor debates in the United States Senate and United States House of Representatives during the 1960s and 1970s informed revisions addressing misbranding, adulteration, and controlled substances enforcement, with oversight by agencies such as the Food and Drug Administration and the Drug Enforcement Administration.
The scope of 21 U.S.C. § 1441 covers prohibited acts and penalties relating to labeling, adulteration, distribution, and importation associated with pharmaceuticals, foodstuffs, and controlled substances as coordinated with 21 U.S.C. § 331 and 21 U.S.C. § 352. Key provisions delineate prohibited conduct, define statutory mens rea elements, and specify the relationship between civil sanctions and criminal prosecution as reflected in enforcement practices of the Department of Justice (United States), United States Attorney General, and administrative orders from the Food and Drug Administration and the Drug Enforcement Administration.
Enforcement of 21 U.S.C. § 1441 is executed through criminal prosecutions and administrative actions pursued by the United States Department of Justice, the Federal Bureau of Investigation, the Food and Drug Administration, and the Drug Enforcement Administration. Penalties range from fines and incarceration under sentencing regimes influenced by the United States Sentencing Commission to injunctions and seizures by the United States Marshals Service, with prosecutorial guidance shaped by precedent from the Supreme Court of the United States and practice manuals issued by the Office of Legal Counsel.
Federal courts, including the Supreme Court of the United States, various United States Courts of Appeals, and district courts, have construed the elements and constitutionality of provisions referenced by 21 U.S.C. § 1441 in opinions involving statutory interpretation, constitutional challenges under the Fourth Amendment to the United States Constitution and Fifth Amendment to the United States Constitution, and administrative law doctrines developed in cases like Chevron U.S.A., Inc. v. Natural Resources Defense Council, Inc., Skidmore v. Swift & Co., and opinions addressing enforcement discretion from the Dissenting opinions of Supreme Court Justices and circuit splits resolved by higher courts.
21 U.S.C. § 1441 functions within an integrated statutory and regulatory framework that includes the Food, Drug, and Cosmetic Act, the Controlled Substances Act, regulations promulgated in the Code of Federal Regulations, and agency guidance from the Food and Drug Administration and the Drug Enforcement Administration. Other adjacent statutes and instruments include 21 U.S.C. § 331, 21 U.S.C. § 333, 21 U.S.C. § 337, rules from the Administrative Procedure Act, and congressional oversight activities by the United States Senate Committee on Health, Education, Labor, and Pensions and the United States House Committee on Oversight and Accountability.
Category:United States federal criminal law